Get started
Author

Nicola Jane Latino

Observed names: N. Latino, N.J. Latino, Nicola J Latino, Nicola J. Latino, Nicola Latino
ORCID: 0000-0001-8225-8635
Observed ORCID: 0000-0001-8225-8635
OpenAlex ID: A5022325252
ESMO-Magnitude of Clinical Benefit Scale version 1.1
2017 · N.I. Cherny, U. Dafni, et al. · Annals of Oncology · 658
PDF
ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe
2023 · A. Bayle, J. Bonastre, et al. · Annals of Oncology · 129
PDF
Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score
2019 · Nathan I. Cherny, Elisabeth G.E. de Vries, et al. · Journal of Clinical Oncology · 125
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)
2025 · N.I. Cherny, S.F. Oosting, et al. · Annals of Oncology · 78
PDF
Access to essential anticancer medicines for children and adolescents in Europe
2020 · G. Vassal, O. Kozhaeva, et al. · Annals of Oncology · 78
PDF
The ‘critical mass’ survey of palliative care programme at ESMO designated centres of integrated oncology and palliative care
2017 · D. Hui, N. Cherny, et al. · Annals of Oncology · 50
PDF
Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
2018 · David Hui, Nathan I Cherny, et al. · ESMO Open · 43
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit
2022 · S.F. Oosting, J. Barriuso, et al. · Annals of Oncology · 40
PDF
ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update
2025 · N.I. Cherny, D. Trapani, et al. · Annals of Oncology · 39
PDF
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
2023 · B. Kiesewetter, U. Dafni, et al. · Annals of Oncology · 37
PDF
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
2022 · G. Zarkavelis, A.L. Amylidi, et al. · ESMO Open · 26
Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
2017 · Urania Dafni, Dimitris Karlis, et al. · ESMO Open · 26
PDF
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
2016 · N.I. Cherny, R. Sullivan, et al. · ESMO Open · 22
PDF
EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
2020 · Barbara Kiesewetter, Nathan I. Cherny, et al. · ESMO Open · 19
PDF
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
2016 · C. Dittrich, M. Kosty, et al. · Annals of Oncology · 19
PDF
Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience
2022 · N.J. Latino, M. Galotti, et al. · ESMO Open · 17
PDF
Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
2020 · Shani Paluch-Shimon, Nathan I. Cherny, et al. · ESMO Open · 15
PDF
MyPath: the roadmap to implementing patient-centred care
2025 · Amaia Urrizola, Alen Brkic, et al. · Academia oncology. · 11
Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
2020 · Daan Geert Knapen, Nathan I. Cherny, et al. · ESMO Open · 10
PDF
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
2023 · F. Roitberg, T. Amaral, et al. · ESMO Open · 3
PDF
Characteristics and level of integration of ESMO Designated Centres of integrated oncology and palliative care
2016 · D. Hui, N. Cherny, et al. · Annals of Oncology · 3
Balancing ideals and realities: health care professionals’ perspectives of and attitudes toward digital patient-centered cancer care
2026 · Elias David Lundereng, Alen Brkic, et al. · Quality of Life Research · 2
PDF
ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
2022 · G. Kreye, T. Lundeby, et al. · ESMO Open · 2
PDF
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data
2026 · Francesco Pignatti, Tarec Christoffer El‐Galaly, et al. · Clinical Pharmacology & Therapeutics · 1
PDF
The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data
2025 · C.G. Urzua-Traslavina, N.J. Latino, et al. · ESMO Real World Data and Digital Oncology · 1
PDF
Works count: 34
Citation count: 1,456
H-index: 16
I10-index: 19
Year
Topic
Type